UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Stereolithographic (SLA) 3D printing of oral modified-release dosage forms.

Wang, J; Goyanes, A; Gaisford, S; Basit, AW; (2016) Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. International Journal of Pharmaceutics , 503 (1-2) pp. 207-212. 10.1016/j.ijpharm.2016.03.016. Green open access

[thumbnail of SLA IJP text only.pdf]
Preview
Text
SLA IJP text only.pdf - Accepted Version

Download (175kB) | Preview

Abstract

The aim of this work was to evaluate the suitability of stereolithography (SLA) to fabricate drug-loaded tablets with modified-release characteristics. The SLA printer creates solid objects by using a laser beam to photopolymerise monomers. In this work polyethylene glycol diacrylate (PEGDA) was used as a monomer and diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide was used as a photo-initiator. 4-aminosalicylic acid (4-ASA) and paracetamol (acetaminophen) were selected as model drugs. Tablets were successfully printed and formulations with different properties were fabricated by adding polyethylene glycol 300 (PEG 300) to the printing solution. The loading of paracetamol and 4-ASA in the printed tablets was 5.69% and 5.40% respectively. In a realistic dynamic dissolution simulation of the gastrointestinal tract, drug release from the tablets was dependent on the composition of the formulations, but independent of dissolution pH. In conclusion SLA 3DP technology allows the manufacture of drug loaded tablets with specific extended-release profiles. In the future this technology could become a manufacturing technology for the elaboration of oral dosage forms, for industrial production or even for personalised dose.

Type: Article
Title: Stereolithographic (SLA) 3D printing of oral modified-release dosage forms.
Location: Netherlands
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.ijpharm.2016.03.016
Publisher version: http://dx.doi.org/10.1016/j.ijpharm.2016.03.016
Language: English
Additional information: © 2016 Elsevier B.V This manuscript is made available under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International license (CC BY-NC-ND 4.0). This license allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Further details about CC BY licenses are available at http://creativecommons.org/ licenses/by/4.0. Access may be initially restricted by the publisher.
Keywords: 4-ASA, Controlled release, Modified release, Paracetamol, Stereolithographic printing, Stereolithography, Three dimensional (3D) printing
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmaceutics
URI: https://discovery.ucl.ac.uk/id/eprint/1477047
Downloads since deposit
2,007Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item